Skip to content

CHASE - Comparing Human and Artificial Intelligence Solution and Expertise

CHASE - Comparing Human and Artificial Intelligence Solution and Expertise - CHASE

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
DRKS
Registry ID
DRKS00035266
Enrollment
20
Registered
2024-12-12
Start date
2024-10-10
Completion date
Unknown
Last updated
2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

The study's participants include individuals currently diagnosed with tobacco dependence under ICD-10 code F17.2 as well as ex-smokers who have ceased smoking for no more than two years

Interventions

Group 1: The study participants, representing the intervention group, ask questions regarding tobacco and nicotine use. These questions are structured and presented to three human experts in a worksho

Sponsors

Klinik und Poliklinik für Psychiatrie und Psychotherapie
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 85 Years

Inclusion criteria

Inclusion criteria: Good knowledge of German, smoker, non-smoker for a maximum of 2 years, high motivation to participate, smoking cessation is not generally denied

Exclusion criteria

Exclusion criteria: Poor knowledge of German language, non-smoker for more than two years, tobacco addiction-naive people, work in the AI sector or in the tobacco industry, a smoking cessation is generally denied

Design outcomes

Primary

MeasureTime frame
The primary endpoint is the determination of the response quality of ChatGPT compared to human experts. This parameter is assessed after the completion of the response evaluation by study participants and the three additional experts. Response quality is measured using evaluations in five predefined categories (information content, safety/ethical harmlessness, applicability, clarity, and empathy) on a five-point Likert scale. The collected evaluations are statistically analyzed to compare the mean scores and distributions of AI versus expert responses. Analysis is conducted during a designated evaluation phase following the collection of all data.

Secondary

MeasureTime frame
Secondary endpoints include the participants' ability to distinguish AI responses from those of human experts in the Turing test, as well as their willingness to rely on AI for advice in addiction-related issues. The Turing test is performed immediately after the evaluation of responses through a targeted question where participants indicate which response they believe was generated by the AI, with results analyzed as correct or incorrect identifications. The willingness to use AI as advisor is assessed following the evaluation process using open qualitative questions, which are analyzed through content analysis.

Countries

Germany

Contacts

Public ContactAndrea;Amanda Rabenstein;Tufman

Klinik für Psychiatrie und Psychotherapie am Klinikum der Universität München;Medizinische Klinik und Poliklinik V, Ludwig-Maximilians-Universität München

Andrea.Rabenstein@med.uni-muenchen.de;Amanda.Tufman@med.uni-muenchen.de004989440055707;089440052590

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026